Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-02 Sale |
2023-03-03 09:27 am |
OPIANT PHARMACEUTICALS INC. | OPNT | Silver Gabrielle Alison Director |
23,343 | $20 | $466,860 | 0 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 09:25 am |
OPIANT PHARMACEUTICALS INC. | OPNT | Collard Craig A Director |
55,822 | $20 | $1,116,440 | 0 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 09:22 am |
OPIANT PHARMACEUTICALS INC. | OPNT | Ruth Matthew R. Chief Commercial Officer |
31,916 | $20 | $638,320 | 0 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 09:20 am |
OPIANT PHARMACEUTICALS INC. | OPNT | Daly Richard J Director |
7,800 | $20 | $156,000 | 0 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 09:18 am |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
87,106 | $20 | $1,742,120 | 0 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 09:16 am |
OPIANT PHARMACEUTICALS INC. | OPNT | Ellison Mark Jason Heath Chief Development Officer |
30,431 | $20 | $608,620 | 0 (Indirect Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 09:13 am |
OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer |
23,548 | $20 | $470,960 | 0 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 09:10 am |
OPIANT PHARMACEUTICALS INC. | OPNT | Sinclair Michael Director 10% Owner |
90,170 | $20 | $1,803,400 | 0 (Indirect Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 09:08 am |
OPIANT PHARMACEUTICALS INC. | OPNT | MacDougall Ann L. Director |
28,179 | $20 | $563,580 | 0 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 09:05 am |
OPIANT PHARMACEUTICALS INC. | OPNT | Lorianne Masuoka K. Director |
4,000 | $20 | $80,000 | 0 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 09:03 am |
OPIANT PHARMACEUTICALS INC. | OPNT | Gorman Brian General Counsel |
33,990 | $20 | $679,800 | 0 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 09:00 am |
OPIANT PHARMACEUTICALS INC. | OPNT | Thomas Thomas T. Director |
12,375 | $20 | $247,500 | 0 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 08:57 am |
OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer |
36,248 | $20 | $724,960 | 0 (Direct) |
View |
| 2023-01-27 Sale |
2023-01-31 4:22 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
1,358 | $20.26 | $27,513 | 75,339 (Direct) |
View |
| 2023-01-27 Sale |
2023-01-31 4:21 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Ellison Mark Jason Heath Chief Development Officer |
610 | $20.26 | $12,359 | 18,751 (Direct) |
View |
| 2023-01-27 Sale |
2023-01-31 4:20 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Gorman Brian General Counsel |
444 | $20.26 | $8,995 | 31,990 (Direct) |
View |
| 2023-01-27 Sale |
2023-01-31 4:19 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer |
480 | $20.26 | $9,725 | 21,548 (Direct) |
View |
| 2023-01-27 Sale |
2023-01-31 4:17 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer |
541 | $20.26 | $10,961 | 34,248 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-09 5:16 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer |
415 | $20.2 | $8,383 | 34,789 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-09 5:13 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Ellison Mark Jason Heath Chief Development Officer |
469 | $20.2 | $9,474 | 19,361 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-09 5:11 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer |
369 | $20.2 | $7,454 | 22,028 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-09 5:09 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
1,183 | $20.2 | $23,897 | 76,697 (Direct) |
View |
| 2023-01-05 Sale |
2023-01-05 5:07 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Ellison Mark Jason Heath Chief Development Officer |
1,806 | $20.2 | $36,481 | 19,830 (Direct) |
View |
| 2023-01-05 Sale |
2023-01-05 5:03 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer |
1,600 | $20.2 | $32,320 | 35,204 (Direct) |
View |
| 2023-01-05 Sale |
2023-01-05 4:59 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Gorman Brian General Counsel |
1,313 | $20.2 | $26,523 | 32,434 (Direct) |
View |
| 2023-01-05 Sale |
2023-01-05 4:56 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer |
1,421 | $20.2 | $28,704 | 22,397 (Direct) |
View |
| 2023-01-05 Sale |
2023-01-05 4:52 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
5,029 | $20.2 | $101,586 | 77,880 (Direct) |
View |
| 2022-07-20 Sale |
2022-07-21 4:08 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Ruth Matthew R. Chief Commercial Officer |
1,084 | $10.62 | $11,512 | 29,916 (Direct) |
View |
| 2022-07-14 Sale |
2022-07-15 4:06 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer |
779 | $11.1 | $8,647 | 36,804 (Direct) |
View |
| 2022-07-14 Sale |
2022-07-15 4:05 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer |
627 | $11.85 | $7,430 | 23,818 (Direct) |
View |
| 2022-07-14 Sale |
2022-07-15 4:04 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Gorman Brian General Counsel |
691 | $11.16 | $7,712 | 33,747 (Direct) |
View |
| 2022-07-14 Sale |
2022-07-15 4:03 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
2,246 | $11.11 | $24,953 | 82,909 (Direct) |
View |
| 2022-06-13 Sale |
2022-06-15 4:30 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Sinclair Michael Director 10% Owner |
13,616 | $10.96 | $149,188 | 19,220 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-02 Option Award |
2023-03-03 09:22 am |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Ruth Matthew R. Chief Commercial Officer |
2,000 | $0 | 0 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-03 09:18 am |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
6,667 | $0 | 0 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-03 09:16 am |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Ellison Mark Jason Heath Chief Development Officer |
2,000 | $0 | 0 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-03 09:13 am |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer |
2,000 | $0 | 0 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-03 09:05 am |
N/A 2031-03-17 |
OPIANT PHARMACEUTICALS INC. | OPNT | Lorianne Masuoka K. Director |
5,000 | $0 | 0 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-03 09:03 am |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Gorman Brian General Counsel |
2,000 | $0 | 0 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-03 08:57 am |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer |
2,000 | $0 | 0 (Direct) |
View |
| 2022-06-27 Option Award |
2022-06-29 4:07 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Ellison Mark Jason Heath Chief Development Officer |
2,000 | $0 | 21,636 (Direct) |
View |
| 2022-06-27 Option Award |
2022-06-29 4:06 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
6,667 | $0 | 85,155 (Direct) |
View |
| 2022-06-27 Option Award |
2022-06-29 4:04 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer |
2,000 | $0 | 37,583 (Direct) |
View |
| 2022-06-27 Option Award |
2022-06-29 4:03 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer |
2,000 | $0 | 24,445 (Direct) |
View |
| 2022-06-27 Option Award |
2022-06-29 4:02 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Gorman Brian General Counsel |
2,000 | $0 | 34,438 (Direct) |
View |
| 2022-06-27 Option Award |
2022-06-29 4:01 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Ruth Matthew R. Chief Commercial Officer |
2,000 | $0 | 31,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-14 5:00 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Collard Craig A Director |
2,000 | $0 | 55,822 (Direct) |
View |